Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy
TCTR20170715003Phase 4Completed
- Sponsor
- Department of Anesthesiology
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in major depressive disorder (MDD), sponsored by Department of Anesthesiology. Started Jul 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20170715003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170715003.